(Q46506474)

22 December 2017

title

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children (English)

1 reference

22 December 2017

author

Peter Godfrey-Faussett

6

Peter Godfrey-Faussett

1 reference

22 December 2017

Nulda Beyers

7

Nulda Beyers

1 reference

22 December 2017

Anneke C Hesseling

1

Anneke C Hesseling

1 reference

22 December 2017

Robert P Gie

3

Robert P Gie

1 reference

22 December 2017

Hendrik Simon Schaaf

4

H Simon Schaaf

1 reference

22 December 2017

author name string

Ben J Marais

2

1 reference

22 December 2017

Paul E M Fine

5

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

22 December 2017

published in

Vaccine

1 reference

22 December 2017

volume

25

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

14-18

1 reference

22 December 2017

A review of vaccine research and development: tuberculosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

Immunological conditions of children with BCG disseminated infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

Disseminated bacille Calmette-Guérin disease after vaccination: case report and review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

Criteria for Identification of Cross-Contamination of Cultures of Mycobacterium tuberculosis in Routine Microbiology Laboratories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

PCR identification of Mycobacterium bovis BCG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.07.020

1 reference

22 December 2017

PubMed ID

16959383

1 reference

22 December 2017